Noucor Health

Executive Summary

Noucor Health is a Spanish chemical-pharmaceutical company founded in 2021 and headquartered near Barcelona. Operating on a B2B model, the company focuses on the research, development, licensing, manufacturing, and supply of pharmaceutical products, including new chemical entities, generics, and value-added medicines. With three manufacturing plants, Noucor produces active pharmaceutical ingredients, finished dosage forms, and food supplements, serving over 100 global markets. The company's integrated approach allows it to offer end-to-end solutions from R&D to commercial supply, positioning it as a versatile partner in the pharmaceutical supply chain. Despite its relatively recent founding, Noucor has established a broad geographic footprint and diversified product portfolio. However, as a private company, it does not disclose financial performance or pipeline details. The lack of public information limits visibility into its growth trajectory and competitive positioning. While its manufacturing capabilities and global reach suggest operational scale, the absence of disclosed revenue, funding, or clinical-stage assets makes it challenging to assess its near-term potential. The company likely benefits from steady demand in generics and contract manufacturing but faces competition from larger, more established players.